Susie Harborth is General Partner and CFO of BioInnovation Capital, an early stage life science venture capital firm. She co-founded and oversees BioLabs San Diego and the BioLabs network. From 2010 to 2014, Susie was Chief Financial Officer (CFO) and Senior Vice President of Operations at GnuBIO, Inc., a next-generation DNA sequencing company that was spun out of Harvard University. GnuBIO was acquired in 2014 by Bio-Rad Laboratories. Susie specializes in launching early-stage life science companies, supporting founders from idea to exit. Prior to GnuBIO, she helped launch two successful start-ups with Peter Parker: Cequent Pharmaceuticals and Boston Heart Diagnostics. She developed the initial infrastructure at both ventures and provided management in finance, human resources, information technology, and vendor/investor relations. Prior to Cequent Pharmaceuticals, Susie worked with institutional investors at Leerink Partners LLC, a life science investment bank. She received a master in biology from Harvard University and did her graduate research in breast cancer diagnostics at Massachusetts General Hospital (MGH) and bachelors in finance from California State University, Long Beach.
Message speakers and other attendees through the Whova app!Get Started